TETRAGRAPH® | EMG BASED QUANTITATIVE NEUROMUSCULAR MONITOR

A world without anesthesia- and respiratory-related complications

Read more

A Swedish medical technology company

Senzime develops, manufactures and markets CE- and FDA-cleared patient monitoring systems. The goal is to help eliminate in-hospital complications, and radically reduce healthcare costs related to surgical and high acuity procedures.

Our vision is a world without anesthesia- and respiratory-related complications.

CEO Statement

Growth in the first quarter was clear. Total sales growth was 64 percent, with the U.S. accounting for the largest increase, 109 percent year-over-year, and Europe up 36 percent. Sensor sales increased by 44 percent during the quarter compared to the same period in 2021.

Pia Renaudin
CEO

Explore our patient monitoring solutions

Get product details

How can Senzime’s products help to eliminate in-hospital complications?
Contact us to discuss your needs or schedule a product demo.